Cecilia Sahlgren

Surface Modification of Mesoporous Silica Nanoparticles as a Means to Introduce Inherent Cancer-Targeting Ability in a 3D Tumor Microenvironment (2024)

Small Science

Prabhakar, Neeraj; Långbacka, Erica; Özliseli, Ezgi; Mattsson, Jesse; Mahran, Alaa; Suleymanova, Ilida; Sahlgren, Cecilia; Rosenholm, Jessica M.; Åkerfelt, Malin; Nees, Matthias

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Germline-specific RNA helicase DDX4 forms cytoplasmic granules in cancer cells and promotes tumor growth (2024)

Cell Reports

Olotu, Opeyemi; Koskenniemi, Anna-Riina; Ma, Lin; Paramonov, Valeriy; Laasanen, Sini; Louramo, Elina; Bourgery, Matthieu; Lehtiniemi, Tiina; Laasanen, Samuli; Rivero-Müller, Adolfo; Löyttyniemi, Eliisa; Sahlgren, Cecilia; Westermarck, Jukka; Ventelä, Sami; Visakorpi, Tapio; Poutanen, Matti; Vainio, Paula; Mäkelä, Juho-Antti; Kotaja, Noora

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Directing cellular responses in a nanocomposite 3D matrix for tissue regeneration with nanoparticle-mediated drug delivery (2023)

Materials today. Bio

Özliseli Ezgi, Sanlidag Sami, Süren Behice, Mahran Alaa, Parikainen Marjaana, Sahlgren Cecilia, Rosenholm Jessica M.

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Modulating epigenetic modifications for cancer therapy (Review) (2023)

Oncology Reports

Castro-Muñoz Leonardo Josué, Ulloa Elenaé Vázquez, Sahlgren Cecilia, Lizano Marcela, de la Cruz-Hernández Erick, Contreras-Paredes Adriana

(Vertaisarvioitu katsausartikkeli tieteellisessä aikakauslehdessä (A2))

Organ-on-a-chip technologies for biomedical research and drug development: A focus on the vasculature (2023)

Smart medicine

Soto Veliz Diosangeles, Lin Kai-Lan, Sahlgren Cecilia

(Vertaisarvioitu katsausartikkeli tieteellisessä aikakauslehdessä (A2))

Mechanical regulation of the Notch signaling pathway (2023)

Current Opinion in Cell Biology

Suarez Rodriguez Freddy, Sanlidag Sami, Sahlgren Cecilia

(A2 Vertaisarvioitu katsausartikkeli tieteellisessä lehdessä)

An in vitro model of cancer invasion with heterogeneous ECM created with droplet microfluidics (2023)

Frontiers in Bioengineering and Biotechnology

Jouybar Mohammad, Sleeboom Jelle J.F., Vaezzadeh Elnaz, Sahlgren Cecilia M., den Toonder Jaap M.J.

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Reversible and bidirectional signaling of notch ligands (2022)

Critical Reviews in Biochemistry and Molecular Biology

Vázquez-Ulloa Elenaé, Lin Kai-Lan, Lizano Marcela, Sahlgren Cecilia

(Vertaisarvioitu katsausartikkeli tieteellisessä aikakauslehdessä (A2))

GIT1 protects against breast cancer growth through negative regulation of Notch (2022)

Nature Communications

Zhang Songbai, Miyakawa Ayako, Wickström Malin, Dyberg Cecilia, Louhivuori Lauri, Varas-Godoy Manuel, Kemppainen Kati, Kanatani Shigeaki, Kaczynska Dagmara, Ellström Ivar Dehnisch, Elfman Lotta, Kronqvist Pauliina, Repo Heli, Mikoshiba Katsuhiko, Sahlgren Cecilia, Johnsen John Inge, Uhlén Per

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

An N-glycan on the C2 domain of JAGGED1 is important for Notch activation (2022)

Science Signaling

Meng Yao, Sanlidag Sami, Jensen Sacha A, Burnap Sean A, Struwe Weston B, Larsen Andreas H, Feng Xinyi, Mittal Shruti, Sansom Mark SP, Sahlgren Cecilia, Handford Penny A

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Contact

Publications

Sort by:

Surface Modification of Mesoporous Silica Nanoparticles as a Means to Introduce Inherent Cancer-Targeting Ability in a 3D Tumor Microenvironment (2024)

Germline-specific RNA helicase DDX4 forms cytoplasmic granules in cancer cells and promotes tumor growth (2024)

Directing cellular responses in a nanocomposite 3D matrix for tissue regeneration with nanoparticle-mediated drug delivery (2023)

Modulating epigenetic modifications for cancer therapy (Review) (2023)

Organ-on-a-chip technologies for biomedical research and drug development: A focus on the vasculature (2023)

Mechanical regulation of the Notch signaling pathway (2023)

An in vitro model of cancer invasion with heterogeneous ECM created with droplet microfluidics (2023)

Reversible and bidirectional signaling of notch ligands (2022)

GIT1 protects against breast cancer growth through negative regulation of Notch (2022)

An N-glycan on the C2 domain of JAGGED1 is important for Notch activation (2022)